North China Pharmaceutical Co Ltd
North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China and internationally. The company primarily offers anti-infective drugs, biotechnology drugs, cardiovascular cerebrovascular, immunomodulators, and vitamins and health products. It also provides chemical pharmaceuticals; and biological, agricultural, and veterin… Read more
North China Pharmaceutical Co Ltd (600812) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.026x
Based on the latest financial reports, North China Pharmaceutical Co Ltd (600812) has a cash flow conversion efficiency ratio of 0.026x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥170.24 Million) by net assets (CN¥6.67 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
North China Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how North China Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
North China Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of North China Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangdong Eastone Century Technology Co Ltd
SHE:300310
|
-0.086x |
|
Jiangmen iDear-Hanyu Electrical Joint-Stock Co Ltd
SHE:300403
|
0.034x |
|
Clas Ohlson AB ser. B
LSE:0GQE
|
0.094x |
|
Italmobiliare S.p.A.
LSE:0RP4
|
-0.006x |
|
Toyobo Co. Ltd
F:TO7
|
0.029x |
|
Rumble Inc.
NASDAQ:RUM
|
-0.035x |
|
KIWETINOHK ENERGY
F:Y9B
|
N/A |
|
Asana Inc
NYSE:ASAN
|
0.086x |
Annual Cash Flow Conversion Efficiency for North China Pharmaceutical Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of North China Pharmaceutical Co Ltd from 1998 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥6.67 Billion | CN¥1.23 Billion | 0.184x | +12.77% |
| 2023-12-31 | CN¥6.27 Billion | CN¥1.02 Billion | 0.163x | +1.30% |
| 2022-12-31 | CN¥6.23 Billion | CN¥1.00 Billion | 0.161x | +7.75% |
| 2021-12-31 | CN¥7.02 Billion | CN¥1.05 Billion | 0.150x | +40.40% |
| 2020-12-31 | CN¥7.06 Billion | CN¥752.15 Million | 0.107x | -18.20% |
| 2019-12-31 | CN¥5.62 Billion | CN¥732.97 Million | 0.130x | -7.23% |
| 2018-12-31 | CN¥5.51 Billion | CN¥774.33 Million | 0.140x | +158.25% |
| 2017-12-31 | CN¥5.28 Billion | CN¥287.25 Million | 0.054x | +164.46% |
| 2016-12-31 | CN¥5.29 Billion | CN¥-446.53 Million | -0.084x | -463.04% |
| 2015-12-31 | CN¥5.27 Billion | CN¥122.50 Million | 0.023x | +34.66% |
| 2014-12-31 | CN¥5.25 Billion | CN¥90.56 Million | 0.017x | +153.00% |
| 2013-12-31 | CN¥4.15 Billion | CN¥-135.03 Million | -0.033x | -112.90% |
| 2012-12-31 | CN¥4.18 Billion | CN¥-63.92 Million | -0.015x | -108.83% |
| 2011-12-31 | CN¥1.31 Billion | CN¥227.60 Million | 0.173x | +134.21% |
| 2010-12-31 | CN¥1.18 Billion | CN¥-598.35 Million | -0.506x | -144.62% |
| 2009-12-31 | CN¥890.92 Million | CN¥1.01 Billion | 1.135x | +74.64% |
| 2008-12-31 | CN¥1.67 Billion | CN¥1.09 Billion | 0.650x | +42.40% |
| 2007-12-31 | CN¥1.46 Billion | CN¥664.37 Million | 0.456x | +6.25% |
| 2006-12-31 | CN¥1.39 Billion | CN¥597.12 Million | 0.430x | +179.39% |
| 2005-12-31 | CN¥1.46 Billion | CN¥224.17 Million | 0.154x | -14.81% |
| 2004-12-31 | CN¥1.72 Billion | CN¥310.39 Million | 0.180x | -14.31% |
| 2003-12-31 | CN¥2.76 Billion | CN¥580.32 Million | 0.211x | -23.91% |
| 2002-12-31 | CN¥2.67 Billion | CN¥738.50 Million | 0.277x | +103.57% |
| 2001-12-31 | CN¥2.70 Billion | CN¥367.28 Million | 0.136x | +175.41% |
| 2000-12-31 | CN¥2.70 Billion | CN¥133.49 Million | 0.049x | +135.17% |
| 1999-12-31 | CN¥2.66 Billion | CN¥-373.62 Million | -0.140x | +17.86% |
| 1998-12-31 | CN¥1.91 Billion | CN¥-326.74 Million | -0.171x | -- |